These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 34333075)

  • 41. Cancer immunotherapy using gene-modified dendritic cells.
    Ribas A; Butterfield LH; Glaspy JA; Economou JS
    Curr Gene Ther; 2002 Feb; 2(1):57-78. PubMed ID: 12108974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanotechnology in the arena of cancer immunotherapy.
    Asadujjaman M; Cho KH; Jang DJ; Kim JE; Jee JP
    Arch Pharm Res; 2020 Jan; 43(1):58-79. PubMed ID: 31956965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advances in ultrasound-triggered therapy.
    Yang C; Li Y; Du M; Chen Z
    J Drug Target; 2019 Jan; 27(1):33-50. PubMed ID: 29659307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Development of Nucleic Acid-Based Adjuvant for Cancer Immunotherapy].
    Kobiyama K; Ishii KJ
    Gan To Kagaku Ryoho; 2015 Sep; 42(9):1040-5. PubMed ID: 26469159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review.
    Phung CD; Tran TH; Kim JO
    Arch Pharm Res; 2020 Jan; 43(1):32-45. PubMed ID: 31993969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoparticle-siRNA: A potential cancer therapy?
    Young SW; Stenzel M; Yang JL
    Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
    Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suicide-gene transfection of tumor-tropic placental stem cells employing ultrasound-responsive nanoparticles.
    Paris JL; de la Torre P; Cabañas MV; Manzano M; Flores AI; Vallet-Regí M
    Acta Biomater; 2019 Jan; 83():372-378. PubMed ID: 30414488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of new immunotherapy treatments in different cancer types.
    Stanculeanu DL; Daniela Z; Lazescu A; Bunghez R; Anghel R
    J Med Life; 2016; 9(3):240-248. PubMed ID: 27974927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Development of Ultrasound Theranostics for Cancer].
    Suzuki R; Maruyama K
    Yakugaku Zasshi; 2018; 138(7):919-922. PubMed ID: 29962469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sonodynamic therapy-derived multimodal synergistic cancer therapy.
    Xu M; Zhou L; Zheng L; Zhou Q; Liu K; Mao Y; Song S
    Cancer Lett; 2021 Jan; 497():229-242. PubMed ID: 33122099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of ultrasound in transfection and transgene expression.
    Rome C; Deckers R; Moonen CT
    Handb Exp Pharmacol; 2008; (185 Pt 2):225-43. PubMed ID: 18626604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nucleic acid nanotechnology for cancer treatment.
    Jin JO; Kim G; Hwang J; Han KH; Kwak M; Lee PCW
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188377. PubMed ID: 32418899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy.
    Yang R; Chen L; Wang Y; Zhang L; Zheng X; Yang Y; Zhu Y
    Front Immunol; 2023; 14():1237361. PubMed ID: 37575228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of nanotechnology in circumventing immunotolerance.
    Ma Y; Shen Y; Zhu B; Li D; Liu J
    Pharmazie; 2020 Oct; 75(10):470-477. PubMed ID: 33305719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in applying nanotechnologies for cancer immunotherapy.
    Mahjub R; Jatana S; Lee SE; Qin Z; Pauli G; Soleimani M; Madadi S; Li SD
    J Control Release; 2018 Oct; 288():239-263. PubMed ID: 30223043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy.
    Meng F; Wang J; Yeo Y
    J Control Release; 2022 May; 345():586-600. PubMed ID: 35351528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.